Let’s look at the key reasons that are pushing Pediatrix Medical Group Inc (MD) to new highs

On Tuesday, Pediatrix Medical Group Inc (NYSE: MD) opened lower -2.46% from the last session, before settling in for the closing price of $9.74. Price fluctuations for MD have ranged from $7.70 to $15.20 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -7.30%. Company’s average yearly earnings per share was noted -1.27% at the time writing. With a float of $83.13 million, this company’s outstanding shares have now reached $84.12 million.

Pediatrix Medical Group Inc (MD) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Pediatrix Medical Group Inc is 1.18%, while institutional ownership is 98.34%. The most recent insider transaction that took place on Dec 14 ’23, was worth 55,219. In this transaction Chief Executive Officer of this company sold 5,764 shares at a rate of $9.58, taking the stock ownership to the 90,874 shares. Before that another transaction happened on Dec 14 ’23, when Company’s EVP, General Counsel & Sec sold 1,150 for $9.62, making the entire transaction worth $11,063. This insider now owns 15,730 shares in total.

Pediatrix Medical Group Inc (MD) Recent Fiscal highlights

If we go through the results of last quarter, which was made public on 12/30/2023, the company posted $0.32 earnings per share (EPS) for the quarter, besting the agreed prediction (set at $0.32) by $0. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.35 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -1.27% per share during the next fiscal year.

Pediatrix Medical Group Inc (NYSE: MD) Trading Performance Indicators

Check out the current performance indicators for Pediatrix Medical Group Inc (MD). In the past quarter, the stock posted a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.40. Likewise, its price to free cash flow for the trailing twelve months is 5.99.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit 0.19 in the next quarter and is forecasted to reach 1.29 in one year’s time.

Technical Analysis of Pediatrix Medical Group Inc (MD)

Compared to the last year’s volume of 0.73 million, its volume of 0.63 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 60.44%. Additionally, its Average True Range was 0.37.

During the past 100 days, Pediatrix Medical Group Inc’s (MD) raw stochastic average was set at 72.58%, which indicates a significant increase from 42.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.66% in the past 14 days, which was lower than the 42.33% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $9.25, while its 200-day Moving Average is $11.28. Nevertheless, the first resistance level for the watch stands at $9.66 in the near term. At $9.83, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.07. If the price goes on to break the first support level at $9.25, it is likely to go to the next support level at $9.01. Now, if the price goes above the second support level, the third support stands at $8.84.

Pediatrix Medical Group Inc (NYSE: MD) Key Stats

There are currently 84,123K shares outstanding in the company with a market cap of 799.14 million. Presently, the company’s annual sales total 1,995 M according to its annual income of -60,410 K. Last quarter, the company’s sales amounted to 496,440 K and its income totaled -124,290 K.